Ratings by Roth/MKM (Max Masucci)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 10/22/2026 | Natera | NTRA | New Coverage | Buy (N/A) |
413.38 (404.90) |
-2.05% | Details | |
| 10/22/2026 | Guardant Health | GH | New Coverage | Buy (N/A) |
166.66 (173.25) |
3.95% | Details | |
| 9/29/2026 | Nautilus Biotechnology | NAUT | New Coverage | Buy (N/A) |
0.96 (2.44) |
154.17% | Details | |
| 9/29/2026 | Rapid Micro Biosystems Inc | RPID | New Coverage | Buy (N/A) |
1.11 (0.79) |
-28.83% | Details | |
| 8/5/2026 | Alpha Teknova Inc. | TKNO | New Coverage | Buy (N/A) |
5.30 (6.59) |
24.34% | Details | |
| 8/4/2026 | Exagen | XGN | Maintain | Buy (N/A) |
|
Details | ||
| 7/29/2026 | 908 Devices Inc. | MASS | New Coverage | Buy (N/A) |
7.13 (11.65) |
63.39% | Details | |
| 6/24/2026 | Biodesix | BDSX | New Coverage | Buy (N/A) |
19.16 (21.26) |
10.96% | Details | |
| 6/24/2026 | Castle Biosciences | CSTL | New Coverage | Buy (N/A) |
21.38 (33.30) |
55.75% | Details | |
| 6/24/2026 | Exagen | XGN | New Coverage | Buy (N/A) |
4.36 (7.47) |
71.33% | Details |
